Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Scott Doak | M | 62 |
Nodus Oncology Ltd.
 Nodus Oncology Ltd. BiotechnologyHealth Technology Nodus Oncology Ltd. develops therapies that target DDR (DNA damage response) to treat cancer. The company is based in Edinburgh, UK. The British company was founded in 2020. The CEO is Ian David Waddell. | - |
| Ian Waddell | M | 61 |
Nodus Oncology Ltd.
Nodus Oncology Ltd. BiotechnologyHealth Technology Nodus Oncology Ltd. develops therapies that target DDR (DNA damage response) to treat cancer. The company is based in Edinburgh, UK. The British company was founded in 2020. The CEO is Ian David Waddell. | - |
| Nicola Broughton | M | - |
Nodus Oncology Ltd.
Nodus Oncology Ltd. BiotechnologyHealth Technology Nodus Oncology Ltd. develops therapies that target DDR (DNA damage response) to treat cancer. The company is based in Edinburgh, UK. The British company was founded in 2020. The CEO is Ian David Waddell. | 2 jaar |
| Clare Wareing | M | 61 |
Nodus Oncology Ltd.
Nodus Oncology Ltd. BiotechnologyHealth Technology Nodus Oncology Ltd. develops therapies that target DDR (DNA damage response) to treat cancer. The company is based in Edinburgh, UK. The British company was founded in 2020. The CEO is Ian David Waddell. | - |
| Bert Klebl | M | - |
Nodus Oncology Ltd.
Nodus Oncology Ltd. BiotechnologyHealth Technology Nodus Oncology Ltd. develops therapies that target DDR (DNA damage response) to treat cancer. The company is based in Edinburgh, UK. The British company was founded in 2020. The CEO is Ian David Waddell. | - |
| Julia Mary Brown | F | 58 |
Nodus Oncology Ltd.
Nodus Oncology Ltd. BiotechnologyHealth Technology Nodus Oncology Ltd. develops therapies that target DDR (DNA damage response) to treat cancer. The company is based in Edinburgh, UK. The British company was founded in 2020. The CEO is Ian David Waddell. | 2 jaar |
| Manuelle Debunne | M | - |
Nodus Oncology Ltd.
Nodus Oncology Ltd. BiotechnologyHealth Technology Nodus Oncology Ltd. develops therapies that target DDR (DNA damage response) to treat cancer. The company is based in Edinburgh, UK. The British company was founded in 2020. The CEO is Ian David Waddell. | 2 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Verenigd Koninkrijk | 7 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Keith Blundy
- Persoonlijk netwerk
